6.09
                                            前日終値:
              $5.54
            開ける:
              $5.65
            24時間の取引高:
                365.93K
            Relative Volume:
              5.68
            時価総額:
                $219.00M
            収益:
              -
            当期純損益:
              $-25.50M
            株価収益率:
              -7.9091
            EPS:
                -0.77
            ネットキャッシュフロー:
                $-30.10M
            1週間 パフォーマンス:
              +10.13%
            1か月 パフォーマンス:
              +4.10%
            6か月 パフォーマンス:
                +52.06%
            1年 パフォーマンス:
              +96.45%
            Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
EPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                EPRX
                            
                             
                        Eupraxia Pharmaceuticals Inc 
                           | 
                    6.09 | 280.30M | 0 | -25.50M | -30.10M | -0.77 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2025-07-24 | 開始されました | Cantor Fitzgerald | Overweight | 
| 2025-06-26 | 開始されました | H.C. Wainwright | Buy | 
| 2025-06-16 | 開始されました | Canaccord Genuity | Speculative Buy | 
| 2025-02-21 | 開始されました | Craig Hallum | Buy | 
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy | 
Eupraxia Pharmaceuticals Inc (EPRX) 最新ニュース
Is Eupraxia Pharmaceuticals Inc. stock ready for a breakoutWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Volatility clustering patterns for Eupraxia Pharmaceuticals Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Is Eupraxia Pharmaceuticals Inc. stock bottoming outTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Why Eupraxia Pharmaceuticals Inc. stock is trending among retail tradersTrade Risk Report & Community Verified Swing Trade Signals - newser.com
Can Eupraxia Pharmaceuticals Inc. stock continue upward trendWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is Eupraxia Pharmaceuticals Inc. stock reversal real or fake2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com
Using data filters to optimize entry into Eupraxia Pharmaceuticals Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Eupraxia Pharmaceuticals Inc. stock prediction for this weekPortfolio Growth Summary & Community Verified Trade Alerts - newser.com
(EPRX.WT.A) Stock Analysis and Trading Signals - news.stocktradersdaily.com
Will Eupraxia Pharmaceuticals Inc. stock see insider buyingWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com
Is Eupraxia Pharmaceuticals Inc. reversing from oversold territoryNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Regression analysis insights on Eupraxia Pharmaceuticals Inc. performanceJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
(EPRX) Stock Trading Blueprint (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. stock trend forecastM&A Rumor & Safe Entry Trade Reports - newser.com
Research Analysts Offer Predictions for EPRX FY2025 Earnings - MarketBeat
Strategies to average down on Eupraxia Pharmaceuticals Inc.July 2025 Earnings & Reliable Trade Execution Plans - newser.com
Eupraxia Pharmaceuticals Inc. (EPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to Strong-Buy at Leede Financial - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Expected to Announce Earnings on Thursday - MarketBeat
(EPRX.WT.A) Optimized Trading Opportunities - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. (EPRX.TO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals Advances EoE Treatment with EP-104GI Trial - TipRanks
This analyst loves Eupraxia Pharmaceuticals - Cantech Letter
(EPRX) Trading Strategy and Analysis (EPRX:CA) - news.stocktradersdaily.com
Chart based analysis of Eupraxia Pharmaceuticals Inc. trendsWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Eupraxia Pharmaceuticals Inc (EPRX) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):